Somnoware announced today that the company is launching a program to monitor and assist in the clinical triage of patients impacted by the Philips Respironics device recall. The program will be deployed in collaboration with Kaiser Permanente. Somnoware’s partnership...
DANA POINT, CA, February 8, 2023 — Somnoware Healthcare Systems Inc announced today that the company is partnering with Cerebra Medical Ltd to integrate Cerebra’s autoscoring technology, MY Autoscoring, into the Somnoware platform. This partnership will enable...
Somnoware has been selected as a UCSF Digital Health Award Finalist in the Clinical Diagnostic Tool/Platform category. The Awards honor outstanding health technologies and innovations dramatically transforming healthcare. Somnoware is one of four Best in Class...
Somnoware is proud to announce that our platform has been selected from hundreds of companies as a Quarterfinalist in the Clinical Diagnostic Tool/Platform category for a 2022 UCSF Digital Health Award. The Awards honor outstanding health technologies and innovations...
Somnoware, the leading cloud-based platform for enhanced respiratory care management, announces the release of its Fax Intake Module. The Fax Intake Module transforms paper-based faxing into an all-digital experience. The module streamlines the fax intake process with...
Filling key sleep lab positions, increasing therapy adherence, reimbursement, bringing on the right technology—this is what’s on the minds of sleep medicine professionals in an increasingly difficult-to-navigate sleep medicine landscape. Getting the right answers...
CerraCap Ventures announces its investment in Somnoware, a web-based platform transforming respiratory healthcare and revolutionizing chronic care management. COSTA MESA, Calif., May 12, 2022 /PRNewswire/ -- CerraCap Ventures, an early-stage VC specializing in cyber...
The American Academy of Sleep Medicine released the top 10 noteworthy studies published in the Journal of Clinical Sleep Medicine throughout last year. The studies, ranked by combined page views and downloads, focused primarily on the impact of COVID-19 along with...
New FedRAMP authorization enables Somnoware to rapidly deploy its cloud-based platform across public healthcare systems, provides customers with the guarantee of government-approved security, and sets the stage for future growth. SUNNYVALE, CA, December 13, 2021 —...
A study involving patients with obstructive sleep apnea (OSA) and coronary artery disease (CAD) found that the physiological traits that cause OSA, including lower arousal threshold and both high and low pharyngeal muscle compensation, also influence CPAP adherence....